Ascentage Pharma Announces IND Clearance by the US FDA for F

Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918

Ascentage Pharma Announces IND Clearance by the US FDA for First-in-Human Study of Novel EED Inhibitor APG-5918
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Australia , Hong Kong , Rockville , Western Australia , Suzhou , Jiangsu , Ascentage Pharma , Yifan Zhai , Paul Eder , Joseph Paul Eder , Major National , Drug Administration , Md Anderson Cancer Center , Pfizer , China National Medical Products Administration , Astrazeneca , National Major New Drug Discovery , Dana Farber Cancer Institute , Clinical Director , Early Drug Development Program , Yale Cancer Center , Principal Investigator , Chief Medical Officer , Prof Paul , Main Board , Stock Exchange , Hong Kong Limited , Priority Review , Breakthrough Therapy Designation , Drug Evaluation , Orphan Drug Designation , Fast Track Designation , Orphan Designation , Pediatric Disease , Major National Rd Projects , Major New Drug Discovery , Drug Incubator , Drug Programs , Cancer Center , Mayo Clinic ,